A
AmritaGen develops a novel gene therapy method utilizing Cap-exosomes for targeted drug delivery across the blood-brain barrier. This platform is designed to treat neurodegenerative conditions including Alzheimer's, Parkinson's disease, stroke, and Traumatic Brain Injury. The approach aims to deliver combination therapies to rebuild neural circuits and restore synchronized neuro-glia-vascular activity.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- AmritaGen develops a novel gene therapy method utilizing Cap-exosomes for targeted drug delivery across the blood-brain barrier. This platform is designed to treat neurodegenerative conditions including Alzheimer's, Parkinson's disease, stroke, and Traumatic Brain Injury. The approach aims to deliver combination therapies to rebuild neural circuits and restore synchronized neuro-glia-vascular activity.